TheEdgeResearch
Home / Stocks / TXTM

ProText Mobility, Inc. (TXTM)

OTC Healthcare Biotechnology
$0.01 ▼ -12.66%
Market Cap
$60.7M
Sector
Healthcare
Industry
Biotechnology
Beta
-3.00
52-Wk Range
0.0027-0.014
CEO
Plooy Du Dylon
Country
US
Currency
USD

ProText Mobility, Inc. operates in the Biotechnology industry of the Healthcare sector, headquartered in Fort Lauderdale, FL, US. The stock last traded at $0.01, down 12.66% on the session, giving a market capitalisation of $60.7M. On trailing twelve-month figures it carries a trailing P/E of 69.00, a net margin of 0.0%. Its beta of -3.00 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
69.00
Price / Sales
0.00
Price / Book
0.00
EV / EBITDA
-1023.34
Gross margin
0.0%
Operating margin
0.0%
Net margin
0.0%
Return on equity
—
Debt / equity
0.00
Current ratio
0.00
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
30
IPO date
2003-08-19
Headquarters
Fort Lauderdale, FL, US
About ProText Mobility, Inc.

ProText Mobility, Inc., a biotech company, engages in the development of pharmaceutical botanical medicines. Its medicines are formulated with highly-bioavailable plant extracts. The company is based in Fort Lauderdale, Florida.

Comparable companies

ProText Mobility, Inc. is most often compared with the following Healthcare names:

DVHGFENVBGNCPLEXXPTIXSPRC
More research on TXTM
TXTM technical analysis TXTM TheEdge Score Compare against peers
Open full interactive analysis & DCF →